Can low-grade inflammation reduce T4-to-T3 conversion and lower T3 without raising reverse T3?

Low-grade systemic inflammation significantly alters peripheral thyroid hormone metabolism, shifting thyroid hormone profiles independently of primary thyroid gland dysfunction.

Molecular mechanisms of deiodinase suppression

• Cytokine-driven inhibition: Elevated pro-inflammatory cytokines—specifically interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha), and interleukin-1beta (IL-1beta)—directly suppress the gene expression and enzymatic activity of type 1 (D1) and type 2 (D2) deiodinases.
• Oxidative stress pathways: These cytokines stimulate the generation of reactive oxygen species (ROS) through oxidative stress pathways, including NAD(P)H oxidase. ROS directly impair the outer-ring deiodination required to activate thyroxine (T4) while simultaneously promoting T3-degrading type 3 (D3) deiodinase activity.
• Impact on circulating T3: Because peripheral conversion by D1 and D2 generates approximately 80% to 90% of circulating triiodothyronine (T3), this cytokine-mediated enzymatic impairment directly drives down circulating active T3 levels.

Divergent reverse T3 dynamics

• Context-dependent rT3 levels: While classic non-thyroidal illness syndrome (NTIS) typically features elevated reverse T3 (rT3) due to D3 upregulation, this biochemical response is not universal.
• Normal or low rT3 in chronic states: In specific inflammatory environments and chronic conditions, such as chronic uremia, impaired T4-to-T3 conversion occurs without a concomitant rise in rT3, leaving rT3 levels normal or even reduced.

Bottom line

• Low-grade inflammation suppresses peripheral T4-to-T3 conversion and lowers circulating active T3 through cytokine- and ROS-mediated deiodinase suppression; however, a corresponding increase in reverse T3 is highly context-dependent and is not an obligate marker of this inflammatory impairment.